US FDA approves ImmunityBio's bladder cancer therapy

The U.S. FDA had approved ImmunityBio's combination therapy to treat a type of bladder cancer, the company said on Monday.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)